ENGLEWOOD, Colo., March 11, 2025--(BUSINESS WIRE)--Paragon 28, Inc. (NYSE: FNA) ("Paragon 28" or "Company"), a leading medical device company exclusively focused on the foot and ankle orthopedic ...
ENGLEWOOD, Colo., March 11, 2025--(BUSINESS WIRE)--Paragon 28, Inc. (NYSE: FNA) ("Paragon 28" or "Company"), a leading medical device company exclusively focused on the foot and ankle orthopedic ...
Paragon 28, Inc. (NYSE: FNA) (“Paragon 28” or “Company”), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced the expiration of ...
Paragon 2 (FNA) announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976in connection with the previously announced acquisition of Paragon 28 ...
AI-powered stock picks with a proven track record to beat the S&P 500.
GLUE Monte Rosa Therapeutics, Inc.
INTEREST PAYABLE VALUE 17-Mar-2025 WILL AMOUNT TO: ...
Paragon Financial Partners Inc. trimmed its holdings in Microsoft Co. (NASDAQ:MSFT – Free Report) by 14.7% in the 4th quarter, Holdings Channel reports. The fund owned 7,786 shares of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback